Tour ProBio's Viral Vector Facility
ProBio’s CDMO facility for end-to-end viral vector development and manufacturing includes adeno-associated viral vectors (AAV) and lentiviral vectors (LVV), from gene to GMP, spanning process development, IND-enabling CMC, clinical and commercial manufacturing.
Learn more at: https://www.probiocdmo.com/gene-therapy
Learn more at: https://www.probiocdmo.com/gene-therapy
00:00
00:00